Highlights
- 1
- 2American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
- 3Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020
Publications
152 publications
Funding
12 grantsView NIH portfolio on RePORTER ↗
Active
6 grants- MPIR01DK139249-03Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicitiesNational Institute of Diabetes and Digestive and Kidney Diseases · 2026–2029 · via University of Pennsylvania
- PIU01DK116100-076/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterNational Institute of Diabetes and Digestive and Kidney Diseases · 2017–2028· 2 renewals
- Co-IBP 204524-01Multianalyte Profiling of Kidney Allograft Recipients (Biopharma)CareDx, Inc. · 2020–2027BioPharma Alliance
- MPIR01AI184528-03Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant RecipientsNational Institutes of Health · 2026–2027 · via University of Pennsylvania
- Co-IBP 241334-01Optimization of UroMapCareDx, Inc. · 2023–2027BioPharma Alliance
- MPIR01AI151059-05Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantationNational Institute of Allergy and Infectious Diseases · 2020–2026 · via Cornell University - Ithaca
Completed grants (6)
- Co-IR37AI051652-15Biomolecular Markers for Safe Minimization of ImmunosuppressionNational Institute of Allergy and Infectious Diseases · 2009–2022· 3 renewals
- PISA 184303-01Obese Living Kidney DonorThe Board of Trustees of the University of Alabama for the University of Alabama at Birmingham · 2018–2019Contract
- Co-IHHSN261201700005CValidation of SHADE a Mobile Technology for Monitoring of Ultraviolet ExposureNational Cancer Institute · 2017–2019 · via YouV Labs
- Co-I19Single-Cell RNA Sequencing of Urinary Cells for the Deconvolution of Human Kidney Allograft RejectionMendez National Institute of Transplantation Foundation, The · 2017–2018
- KPR01AI072790-05EWOFoxP3 Regulatory Network mRNA Profiles and Human Renal Transplant OutcomesNational Institute of Allergy and Infectious Diseases · 2007–2011
Clinical research
12 studies
Active
1 study- PINCT02235857Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 SystemNA · Kaneka Pharma America Corporation · OPEN TO ACCRUAL (as of 2019)Focal Segmental Glomerulosclerosis
Completed & closed trials (11)
- PINCT07219121A Multicenter, Open-label Single Arm Study to Evaluate the Safety and Efficacy of Sparsentan in Posttransplant Immunoglobulin A Nephropathy (IgAN) or Focal Segmental Glomerulosclerosis (FSGS) (SPARX)PHASE4 · Travere Therapeutics INC · CLOSED TO ACCRUAL (as of 2026)Proteinuria; Immunoglobulin A (IgA) Nephropathy; Focal Segmental Glomerulosclerosis; Kidney Transplant
- PIImpact of Covid-19 illness on kidney transplant candidates and recipients.Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2026)
- PINCT05769582Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlledPHASE2; PHASE3 · Memo Therapeutics AG · IRB STUDY CLOSURE (as of 2025)BK Viremia; BKV DNAemia
- PINCT05669001A 12-Month, Randomized, Open-Label, Phase IIA Study Evaluating the Safety and Efficacy of Siplizumab in Combination With Belatacept and MPA Compared to Standard of Care Immunosuppression in de Novo Renal Transplant Recipients (ASCEND)PHASE2 · ITB-MED LLC · IRB STUDY CLOSURE (as of 2025)Renal Transplantation
- PIBiomarkers for Detecting and Predicting Infections in Transplant RecipientsWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
- PINCT03326076Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure RegistryCareDx, Inc. · IRB STUDY CLOSURE (as of 2025)Kidney Transplant Rejection
- PIMetagenomic Profiling of Urinary Cell-free DNA to Monitor UTI after Kidney TransplantationWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
- PINCT03744910A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant RecipientsPHASE3 · Vitaeris Inc. · IRB STUDY CLOSURE (as of 2024)Antibody-mediated Rejection
- PIGlobal Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with_x000D_ Posoleucel (ALVR105)AlloVir, Inc. · IRB STUDY CLOSURE (as of 2024)
- PINCT04605484Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Dosing Interval, 2-period Study of the Safety, Tolerability and Effectiveness of Adoptively Transferred Posoleuccel (ALVR105) Multivirus-specific T Cells in Kidney Transplant Recipients With Either High or Low Levels of BK ViremiaPHASE2 · AlloVir, Inc. · IRB STUDY CLOSURE (as of 2023)BK Virus Nephropathy; BK Virus Infection
- PIOUTCOMES OF KIDNEYCARE ON RENAL ALLOGRAFTS (OKRA)- sub-study of EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)CareDx, Inc. · IRB STUDY CLOSURE (as of 2022)
News mentions
2 mentionsView all WCM news ↗
- Intercampus Collaboration Awarded Grant to Develop Method for Diagnosing Urinary Tract Infection Using Cell-Free DNAOctober 14, 2020
An intercampus research team at Weill Cornell Medicine and Cornell’s Ithaca campus has been awarded a five-year, $3.65 million grant from the National Institutes of Health (NIH) to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.
Mentoring
1 mentee
- STStephanie TsaiMD mentee · Class of 2020
External relationships
Leadership Roles
American Society of Transplatation
Professional Services
NIH Center for Scientific Review · UpToDate, Inc.
Other
Memo Therapeutics AG